IRF8-Dependent cDC1s Generate Myosin-Specific Tregs in Heart-Draining Lymph Node
(A) Depicted LNs and spleen were isolated from TCR-M acceptor Irf4fl/fl and Irf4fl/fl.Cd11cCre mice 3 days after naive TCR-M transfer. CFSE dilution and CD44 expression of donor TCR-M cells was analyzed by flow cytometry.
(B) Percentage of proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from the experiment described in (A) (n = 4).
(C) Percentage of T-bet, RoRγt, and Foxp3/CD25 expression on undivided and divided donor TCR-M cells isolated from mLN in Irf4fl/fl and Irf4fl/fl.Cd11cCre steady-state mice (n = 4).
(D) 3 days after naive TCR-M injection, depicted LNs and spleen were isolated from TCR-M acceptor Irf8fl/fl and Irf8fl/fl.Cd11cCre mice. CFSE dilution and CD44 expression of donor TCR-M cells was analyzed by flow cytometry.
(E) Percentage of proliferation and CD44 expression of donor TCR-M cells in LNs and spleen from the experiment described in (D) (n = 5).
(F) Percentage of T-bet, RoRγt, and Foxp3/CD25 expression on undivided and divided donor TCR-M cells isolated from mLN in Irf8fl/fl and Irf8fl/fl.Cd11cCre steady-state mice (n = 5). All data in Figure 3 represent at least three independent experiments, and bar graphs show data as mean ± SEM (∗p ≤ 0.05).